Explore more publications!

Massachusetts Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Healthcare Journal.

Press releases published on October 14, 2025

Arionkoder to Present AI Solutions Improving Diagnostics, Patient Engagement, and Adoption at HLTH USA 2025
Licensing Executives Society (USA & Canada) Announces New Standard for Intellectual Property Valuation
Censinet CCO Cambrey Ware Named to University of Tennessee’s Haslam Healthcare Distinguished Fellows Program
Gray, Gray & Gray Named to ‘Best of the Best’ Accounting Firms
Digital Health 2025: Global Funding Cools as AI and Strategic Partnerships Drive New Growth
LiveData Launches New Analytics Tool, LiveData Insights, with Sauk Prairie Healthcare in Wisconsin as 1st MEDITECH User
Globus Medical Launches ANTHEM™ Elbow Fracture System: A Comprehensive Plating Portfolio for Complex Elbow Trauma
EyePoint Announces Proposed Public Offering of Common Stock
PetMeds® Files Form 10-K for Fiscal 2025
WORK Medical Technology Group LTD Announces Receipt of Delisting Determination Letter from Nasdaq
Elutia to Present at the LD Micro Main Event XIX Conference on Tuesday, October 21
Century Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference
EyePoint Announces Pivotal Phase 3 Program Initiation for DURAVYU™ in Diabetic Macular Edema
Inventiva Announces the Implementation of a New ATM Program
Inventiva annonce la mise en place d’un nouveau programme « At-The-Market » (ATM)
Jeio Tech Partners with LabCentral to Empower Early-Stage Biotech Startups
Oral GLP-1 Tablets Gain Momentum as Telehealth Platform MEDVi Expands Access to Compounded Semaglutide and Tirzepatide for Physician-Supervised Weight Management
Op de AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics kondigt Merus de publicatie aan van het abstract over petosemtamab in gemetastaseerde colorectale kanker
Lung Cancer Antibody Drug Conjugates Market Size FDA Approved Lung Cancer ADC Clinical Trials Future Opportunity Insight
EmblemHealth Achieves 4-Star Medicare Rating, Highlighting Sustained Quality Improvements

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions